Chemical Compound

Liraglutide Impurity 17

Back to search Request a Quote
Liraglutide Impurity 17 chemical structure
Primary Record

Liraglutide Impurity 17

In stock
550 g
Purity
98.1 %

Compound Identifiers & Properties

PubChem CID
177834648
SMILES
CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C
Canonical SMILES
CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O)C(=O)OC(C)(C)C

Names & Synonyms

  • Liraglutide Impurity 17
  • (23R,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
Custom Synthesis

Liraglutide Custom Synthesis Services

Explore our custom synthesis capabilities for Liraglutide-related peptides, building blocks, intermediates, impurities and analytical reference materials. Custom requirements and specifications can be discussed with our team.

Peptide Sequence Modification

Custom sequence variants and terminal modifications for Liraglutide research.

  • Amino Acid Substitution
  • Lys34/Arg34 Sequence Variants
  • D-Amino Acid Incorporation
  • Sequence Truncation
  • Sequence Extension
  • N-Terminal Modification
  • C-Terminal Modification

Liraglutide Analogs

Custom synthesis of structurally modified Liraglutide peptide analogs.

  • Sequence Variants
  • GLP-1 Peptide Analogs
  • Modified Peptide Derivatives

Lipidated Derivatives

Custom studies of Lys26-linked palmitoyl conjugates and related lipidated peptide derivatives.

  • Palmitic Acid (C16) Derivatives
  • Fatty Acid Chain Variants
  • Lys26 Lipidation Variants
  • Lipidated Peptide Analogs

Linkers & Chemical Intermediates

Custom synthesis of glutamyl spacers and lipid-linker building blocks.

  • γ-Glutamyl Linkers
  • Glutamic Acid Spacers
  • Fatty Acid-Linker Intermediates
  • Linker Derivatives

Amino Acid Building Blocks

Custom synthesis of natural, non-natural and protected amino acid building blocks relevant to Liraglutide.

  • Fmoc-Protected Amino Acids
  • Boc-Protected Amino Acids
  • D-Amino Acids
  • Arginine Derivatives
  • Lysine Derivatives
  • Side-Chain Protected Amino Acids
  • Isotope-Labeled Amino Acids

Peptide Fragments

Custom synthesis of Liraglutide-related peptide fragments and protected intermediates.

  • N-Terminal Peptide Fragments
  • C-Terminal Peptide Fragments
  • Internal Peptide Fragments
  • Protected Peptide Fragments
  • Lipidated Peptide Fragments

Impurities & Degradation Products

Custom synthesis of process-related and degradation-related Liraglutide impurities.

  • Deletion Peptide Impurities
  • Insertion Peptide Impurities
  • Sequence-Related Impurities
  • Epimerization Impurities
  • Oxidation Products
  • Deamidation Products
  • Lipidation-Related Impurities

Isotope-Labeled Liraglutide

Custom synthesis of stable isotope-labeled Liraglutide and peptide fragments.

  • 13C-Labeled Liraglutide
  • 15N-Labeled Liraglutide
  • 13C/15N-Labeled Peptides
  • Deuterium-Labeled Peptides
  • Isotope-Labeled Peptide Fragments

Reference Standards

Custom synthesis of analytical reference materials for Liraglutide testing.

  • Liraglutide Reference Standards
  • Working Standards
  • Impurity Reference Standards
  • System Suitability Standards
  • Analytical Peptide Standards